Evidence map›Paper›PMID 33932145›Full record

ArticleFEBS open bio2021

Transfer of stabilising mutations between different secondary active transporter families.

Cristina Cecchetti, Nicola J Scull, Thotegowdanapalya C Mohan, Yilmaz Alguel, Alexandra M C Jones, Alexander D Cameron, Bernadette Byrne

Open access · goldAbstract read
In one paragraph

Article in FEBS open bio, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cristina CecchettiDepartment of Life Sciences, Imperial College London, UK.
Nicola J ScullDepartment of Life Sciences, Imperial College London, UK.
Thotegowdanapalya C MohanSchool of Life Sciences, University of Warwick, Coventry, UK.
Yilmaz AlguelDepartment of Life Sciences, Imperial College London, UK.
Alexandra M C JonesSchool of Life Sciences, University of Warwick, Coventry, UK.
Alexander D CameronSchool of Life Sciences, University of Warwick, Coventry, UK.
Bernadette ByrneDepartment of Life Sciences, Imperial College London, UK.ORCID 0000-0001-9598-9832
Imperial College London · GBUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L015129/1Biotechnology and Biological Sciences Research Council BB/N016467/1Biotechnology and Biological Sciences Research Council BB/N017765/1Wellcome TrustWellcome Trust 104931/Z/14/Z
6 · The paper itself

Abstract

Integral membrane transporters play essential roles in the movement of substrates across biological membranes. One approach to produce transporters suitable for structural studies is to introduce mutations that reduce conformational flexibility and increase stability. However, it can be difficult to predict which mutations will result in a more stable protein. Previously, we stabilised the uric acid-xanthine transporter, UapA, a member of the SLC23 family, through introduction of a single-point mutation, G411V, trapping the protein in the inward-facing conformation. Here, we attempted to stabilise the structurally related BOR1 transporter from Arabidopsis thaliana, a member of the SLC4 family, by introducing the equivalent substitution. We identified possible residues, P362 and M363, in AtBOR1, likely to be equivalent to the G411 of UapA, and generated four mutants, P362V or L and M363F or Y. Stability analysis using heated Fluorescent Size Exclusion Chromatography indicated that the M363F/Y mutants were more stable than the WT AtBOR1 and P362V/L mutants. Furthermore, functional complementation analysis revealed that the M363F/Y mutants exhibited reduced transport activity compared to the P362V/L and WT proteins. Purification and crystallisation of the M363F/Y proteins yielded crystals that diffracted better than WT (5.5 vs 7 Å). We hypothesise that the increased bulk of the F and Y substitutions limits the ability of the protein to undergo the conformational rearrangements associated with transport. These proteins represent a basis for future studies on AtBOR1.

Indexed as

Amino Acid SequenceArabidopsisArabidopsis ProteinsBiological TransportMembrane Transport ProteinsMutationArabidopsis ProteinsMembrane Transport Proteinsintegral membrane proteinmutagenesissecondary active transporterstabilitystructural studies

Identifiers

PMID33932145
PMCPMC8167854
OpenAlexW3158151106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.